latest news in Russell reconstitution

Biotech Firm Vogenx Secures Spot in Key Russell Benchmarks Just Months Post-IPO

Biotech Firm Vogenx Secures Spot in Key Russell Benchmarks Just Months Post-IPO

New York, Thursday, 19 November 2026.
Only four months after going public, Vogenx qualifies for major Russell indexes, positioning the clinical-stage biotech to capture crucial passive institutional investment as FTSE Russell conducts its historic December reconstitution.